Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Unit 7. • Viral infections: 1, Verruca vulgaris, Verruca plana 2, Molluscum contagiosum 3, Herpes simplex 4, Herpes zoster -Etiology, Clinical features, Diagnosis & Treatment. 1 hr • Fungal infections: 1, tinea capitis 2, tinea corporis 3, tinea of feet & hands 4, onychomycosis 5, pityriasis versicolor - Etiology, Clinical features, Diagnosis and Treatment 1 hr Verruca vulgaris (common warts) Verruca plana (flat warts) Etiology: Human Papillomaviruses HPV Types and Morphology and Site of Skin Lesions Lesion Location HPV Genotype Common wart Mostly hands 2, 4 Plantar wart Bottom of feet 1 Mosaic wart Hands and feet 2 Flat wart Arms, face, knees 3, 10, 28, 41 Butcher wart Hand 7 Extragenital Bowen disease Upper and lower extremities, head 2, 3, 5, 16, 18, 20, 31, 33, 34, 54, 56, 58, 61, 62, 73 Macular plaques of epidermodysplasia verruciformis Light-exposed areas 5, 8, 9, 12, 14, 15, 17, 19, 20, 21, 22, 23, 24, 25, 36, 47, 50 Clinical features verrucae vulgaris •occur on any skin surface --usually on hands and fingers •skin-colored-, circumscribed-, rough-, hyperkeratotic papulonodules with minimal irregular scaling •asymptomatic, rare painful •Autoinoculation Clinical features Flat warts, or verrucae plana multiple small flat papules --most occur in groups --less than 5 mm in diameter may induce pigmentation most on the face & hands Spontaneously regression usually occurs Diagnosis of warts Most cutaneous warts can be recognized clinically Histology marked hyperkeratosis acanthosis parakeratosis papillomatosis Differential Diagnosis of Warty Lesions on Hands and Feet Palms and soles Single Lesions Multiple Lesions Consider •Verruca vulgaris •Callus, corn, clavus •Epidermal inclusion cyst •Milkers nodules (palms) •Orf (palms) Consider •Arsenical keratoses •Verruca vulgaris •Palmoplantar keratoderma •Pyogenic granuloma •Psoriasis •Pits in basal cell nevus syndrome Rule Out •Secondary syphilis Rule Out •Amelanotic acrolentiginous melanoma •Carcinoma cuniculatum Dorsum of hands Consider and feet •Verruca vulgaris •Periungual warts •Actinic keratosis Rule Out •Squamous cell carcinoma •Keratoacanthoma •Tuberculosis verrucosa cutis •Fish tank granuloma Consider •Verruca vulgaris •Verrucae planae •Actinic keratosis •Acrokeratosis verruciformis •Stucco keratosis Differential Diagnosis of Plane Warts Face •Perioral dermatitis •Adenoma sebaceum (mild) •Syringomas •Flat seborrheic keratosis •Actinic keratosis •Trichoepitheliomas Hand •Acrokeratosis verruciformis •Lichen planus •Stucco keratosis •Seborrheic keratosis Trunk, Extremities •Epidermodysplasi a verruciformis •Pityriasis versicolor •Superficial actinic porokeratosis •Seborrheic Treatment of warts •Cryotherapy with liquid nitrogen (-196ºC) √ •Laser Carbon dioxide lasers √ pulse dye laser •Antimitotics Podofilox (Condylox, Podophyllotoxin) Podophyllum resin (Pod-Ben-25, Podofin) podophyllotoxin. •Interferons Alfa-, beta-, & gamma•Immunostimulants Imiquimod (Aldara) √ •Antineoplastic agents Fluorouracil (Efudex) •Desiccants Trichloroacetic acid 85% (Tri-Chlor) Molluscum Contagiosum pathogene: a large DNA poxvirus Molluscum contagiosum virus (MCV) Molluscum Contagiosum Clinical feature asymptomatic; some pruritus, tenderness, & pain. self-limited but can persist for several years. Physical: Papules— rounded or dome-shaped, pink, fleshcolored, waxy, smooth, umbilicated contain a caseous plug may be present in groups or widely disseminated 2-5 mm (rarely up to 1 cm) in diameter Immunocompromised conditions Histology Molluscum Contagiosum Cytoplasmic viral inclusions become progressively larger toward the epidermal surface (hematoxylin and eosin, 200X) Molluscum Contagiosum Treatment • Topical applications: Imiquimod cream 5% √ Trichloroacetic acid Cantharidin Tretinoin cream (0.1%) or gel (0.025%) • Cryotherapy with liquid nitrogen • expression & rupture of central core-with tweezers, lasers, curettage Herpes Simplex Etiology: Herpes simplex viruses (HSVs) -- DNA viruses Herpes labialis is caused by HSV type 1 genital herpes is usually caused by HSV type 2 •present as grouped vesicles on an erythematous base •recurrent infection Clinical features Herpes Simplex Primary infection: a prodrome of fever sore throat lymphadenopathy Painful vesicles on the lips, gingiva lesions ulcerate and heal within 2-3 weeks Recurrences: Pain, burning, itching, or paresthesia precedes recurrent vesicular lesions ulcerate or form a crust last approximately 1 week Genital herpes: Herpes Simplex HSV-2 is most common cause Primary infection: occurs within 2 days to 2 weeks after exposure to virus Symptoms typically last 2-3 weeks. Men– painful, erythematous, vesicular lesions ulcerate on penis Womenvesicular/ulcerated lesions on the cervix painful vesicles on the external genitalia bilaterally Associated symptoms-fever, malaise, edema, inguinal lymphadenopathy, dysuria, vaginal or penile discharge Recurrences: Herpes Simplex Diagnosis Depend on clinical features Laboratory Studies Tzanck smear: multinucleated giant cells Serologic assays: to detect antibodies against HSV-1 and HSV-2 Herpes simplex virus: positive Tzanck smear Histopathology of HSV infection Classification of Herpes Simplex Infections According to Viral Isolation and Paired Serologic Test Results Serology (Acute) Classification Serology (Convalescent) Virus Isolated HSV-1 HSV-2 HSV-1 HSV-2 Primary HSV-1 HSV-1 – – + – Primary HSV-2 HSV-2 – – – + Primary HSV-1 plus previous HSV-2 infectiona HSV-1 – + + + Primary HSV-2 plus previous HSV-1 infection HSV-2 + – + + Recurrent HSV-1 HSV-1 + – or + + – or + Recurrent HSV-2 HSV-2 – or + + – or + + Herpes Simplex Treatment Most HSV infections are self-limited. antiviral therapy— may shortens the course prevent dissemination and transmission. Intravenous, oral, and topical antiviral medications: acyclovir, its prodrug valacyclovir, and famciclovir. Immunocompromised pateints with recurrent HSV infections-intravenous cidofovir Herpes Zoster (HZ) shingles Etiology varicella-zoster virus (VZV)— human herpes virus 3 a virus morphologically & antigenically identical to the virus causing varicella (chickenpox). Clinical features of HZ •Symptomsprodromal sensory phenomena along 1 or more skin dermatomes lasting 1-10 days (averaging 48 h) noted as pain or paresthesias prior to onset of cutaneous findings severe pain--"the band of roses from hell." Herpes Zoster classic lesions-grouped vesicles --develops upon the erythematous base --initially clear but eventually cloud, rupture, crust, & involute clinical variations of HZ: •Herpes zoster ophthalmicus (HZO) •Zoster oticus --also termed geniculate zoster zoster auris Ramsay-Hunt syndrome, Hunt syndrome: •Glossopharyngeal and vagal zoster (herpes pharyngis, herpes laryngis): •Disseminated zoster: •Recurrent zoster: Complications of Herpes Zoster Cutaneous •Bacterial superinfection Visceral Neurologic •Pneumonitis •Postherpetic neuralgia •Scarring •Zoster gangrenosum •Cutaneous dissemination •Hepatitis •Meningoencephalitis •Esophagitis •Transverse myelitis •Gastritis •Peripheral nerve palsies •Pericarditis •Motor •Cystitis •Autonomic •Arthritis •Cranial nerve palsies •Sensory loss •Deafness •Ocular complications •Granulomatous angiitis (causing contralateral hemiparesis Dx, & DDx of Herpes Zoster Most Likely •Zosteriform herpes simplex •Contact dermatitis •Insect bites •Burns Consider •Papular urticaria •Erythema multiforme •Drug eruptions •Scabies Always Rule Out Bullous pemphigoid Pemphigus vulgaris Dermatitis herpetiformis Epidermolysis bullosa herpetifo Herpes zoster, histopathology. A. Intraepidermal vesicle, acantholysis, reticular degeneration; underlying dermis shows edema and vasculitis. B. Multinucleated giant cells with characteristic nuclear changes. Treatment of HZ Systemic antiviral agents-Acyclovir its derivatives – valacyclovir, famciclovir, penciclovir, & desciclovir Systemic steroids: only in some sever cases Varicella-zoster vaccine (Zostavax,Merck) Treatment of HZ Patient Normal Regimen Age <50 years Symptomatic treatment alone, or Famciclovir 500 mg PO every 8 h for 7 days or Valacyclovir 1 g PO every 8 h for 7 days or Acyclovir 800 mg PO 5 times a day for 7 daysa Age 50 years, and patientsFamciclovir 500 mg PO every 8 h for 7 days or of any age with cranial Valacyclovir 1 g PO every 8 h for 7 days of nerve involvement (e.g., Acyclovir 800 –mg PO 5 times a day for 7 daysa ophthalmic zoster) Immunocompromised Mild compromise, Famciclovir 500 mg PO every 8 h for 7–10 days or including HIV-1 infection Valacyclovir 1 g PO every 8 h for 7–10 days or Acyclovir 800 mg PO 5 times a day for 7–10 daysa Severe compromise Acyclovir 10 mg/kg IV every 8 h for 7–10 days Acyclovir resistant (e.g., Foscarnet 40 mg/kg IV every 8 h until healed advanced AIDS) Fungal infections: =mycoses •Phyton– from Latin/Greek word for plant •Dermato-phytes– are a group of keratinophilic fungi-invade keratinized tissue (hair, nails, skin) •Dermato-phytosis– is a superficial dermatophytes infection common disorders worldwide Has a variety of clinical manifestations Medical mycoses can be divided into four categories: (1) cutaneous (2) subcutaneous (3) systemic (4) opportunistic The Major Mycoses and Causative Fungi Category Superficial Cutaneous Subcutaneous Mycosis Pityriasis versicolor Tinea nigra White piedra Black piedra Dermatophytosis Candidiasis of skin, mucosa, or nails Sporotrichosis Chromoblastomycosis Causative Fungal Agents Malassezia species Hortaea werneckii Trichosporon species Piedraia hortae Microsporum species, Trichophyton species, and Epidermophyton floccosum Candida albicans and other Candida species Sporothrix schenckii Phialophora verrucosa, Fonsecaea pedrosoi, and others Mycetoma Pseudallescheria boydii, Madurella mycetomatis, and others Phaeohyphomycosis Exophiala, Bipolaris, Exserohilum, and other dematiaceous molds Endemic (primary, Coccidioidomycosis Coccidioides posadasii and Coccidioides systemic) immitis Histoplasmosis Histoplasma capsulatum Blastomycosis Blastomyces dermatitidis Paracoccidioidomycosis Paracoccidioides brasiliensis The Major Mycoses and Causative Fungi Category Mycosis Opportunistic Systemic candidiasis Causative Fungal Agents Candida albicans and many other Candida species Cryptococcosis Cryptococcus neoformans and Cryptococcus gattii Aspergillosis Aspergillus fumigatus and other Aspergillus species Hyalohyphomycosis Species of Fusarium, Paecilomyces, Trichosporon, and other hyaline molds Phaeohyphomycosis Cladophialophora bantiana; species of Alternaria, Cladosporium, Bipolaris, Exserohilum and numerous other dematiaceous molds Mucormycosis (zygomycosis) Species of Rhizopus, Lichtheimia, Cunninghamella, and other zygomycetes Pneumocystis pneumonia Pneumocystis jiroveci Penicilliosis Penicillium marneffei Features of Important Fungal Diseases Type Cutaneous Anatomic Location Genus of Causative Organism(s) Dead layer of skin Tinea versicolor Malassezia Epidermis, hair, nails Dermatophytosis (ringworm) Microsporum, Trichophyton, Epidermophyton Subcutaneous Subcutis Systemic Internal organs Opportunistic Internal organs Representative Disease Sporotrichosis Mycetoma Coccidioidomycosis Sporothrix Several genera Coccidioides Histoplasmosis Blastomycosis Paracoccidioidomycosis Cryptococcosis Histoplasma Blastomyces Paracoccidioides Cryptococcus Candidiasis Aspergillosis Mucormycosis Candida Aspergillus Mucor, Rhizopus Laboratory Test of fungal infaction Laboratory Test Method Potassium hydroxide preparation Scales, subungual debris, KOH solution and gentle or affected hair removed heating softens keratin and placed on a glass slide. and highlights the KOH 10% dropped on, dermatophyte. covered with cover slip. The undersurface of the glass slide is heated. Sabouraud medium (4% Facilitates growth of peptone, 1% glucose, agar, dermatophytes water) Culture Function Modified Sabouraud Facilitates growth of medium (addition of dermatophytes and chloramphenicol, inhibits growth of noncycloheximide, and Candida albicans, gentamicin) Cryptococcus, etc Dermatophyte Scales from the advancing Medium contains the pH test medium border, subungual debris or indicator phenol red. affected hair embedded in the medium. Histolopatholog Tissue may be obtained by Stains fungal cell wall to y special stains: skin or nail biopsy detect fungal elements in PAS,GMS,ect. techniques tissue sections Findings Long narrow septated and branching hyphae Microscopic morphology of microconidia, culture features: surface topography and pigmentation Incubation at room temperature for 5–14 days results in change in color of medium. Pink (PAS) or black (GMS) fungal elements noted in the stratum corneun. Microscopic examination of skin scrapings (scales) revealing septate, branching hyphae. Three genera of dermatophytes. A: Trichophyton tonsurans is characterized by the production of elongated microcondia attached to a supporting hypha. B: Microsporum gypseum produces individual thin- and rough-walled macroconidia. C: Epidermophyton floccosum has club-shaped, thin- and smooth-walled macroconidia that typically arise in small clusters. Tinea tinea -is derived from the Latin word for worm or larvae •tinea capitis (scalp) •tinea corporis (body surfaces) •tinea of hands and feet Tinea manuum and tinea pedis •Onychomycosis ( Tinea unguium ) - Nail •Pityriasis (Tinea) versicolor Tinea cruris - Groin Tinea barbae - Beard area and neck Tinea faciale - Face Majocchi’s granuloma -hair follicle & dermis Risk factors for tinea infection: •Moist conditions •Communal baths •Immunocompromised states ---•Atopy •Genetic predisposition •Athletic activity: causes skin tears, abrasions, or trauma such as wrestling, judo, or soccer Skin Disease Location of Lesions Tinea corporis (ringworm) Nonhairy, smooth skin Clinical Features Fungi Most Frequently Responsible Circular patches with advancing red, Trichophyton rubrum, vesiculated border and central Epidermophyton floccosum scaling. Pruritic Tinea pedis Interdigital spaces on Acute: itching, red vesicular. Trichophyton rubrum, (athlete's foot) feet of persons Chronic: itching, scaling, fissures Trichophyton mentagrophytes, wearing shoes Epidermophyton floccosum Tinea cruris (jock Groin Erythematous scaling lesion in Trichophyton rubrum, itch) intertriginous area. Pruritic Trichophyton mentagrophytes, Epidermophyton floccosum Tinea capitis Scalp hair. Endothrix: Circular bald patches with short hair Trichophyton mentagrophytes, fungus inside hair stubs or broken hair within hair Microsporum canis, shaft. Ectothrix: follicles. Kerion rare. Microsporum- Trichophyton tonsurans fungus on surface of infected hairs fluoresce hair Tinea barbae Beard hair Edematous, erythematous lesion Trichophyton mentagrophytes, Trichophyton rubrum, Trichophyton verrucosum Tinea unguium Nail Nails thickened or crumbling Trichophyton rubrum, (onychomycosis) distally; discolored; lusterless. Trichophyton mentagrophytes, Usually associated with tinea pedis Epidermophyton floccosum Dermatophytid Usually sides and Pruritic vesicular to bullous lesions. No fungi present in lesion. (id reaction) flexor aspects of Most commonly associated with May become secondarily fingers. Palm. Any tinea pedis infected with bacteria site on body Histopathology of Tinea Histopathology of Tinea Treatment of Tinea Disease Tinea corporis /cruris Topical TreatmentSystemic Treatment Allylamines Adults: Imidazoles Terbinafine, 250 mg/day x 2–4 weeks Tolnaftate Itraconazole, 100 mg/day x 1 week Butenafine Fluconazole, 150–300 mg/wk x 4–6 Ciclopirox wks Griseofulvin, 500 mg/day x 2–4 wks Children: Terbinafine, 3–6 mg/kg/day x 2 wks Itraconazole, 5 mg/kg/day x 1 week Griseofulvin, 10–20 mg/kg/day x 2–4 wks Treatment of Tinea Disease Tinea pedis /manuum Topical Treatment Allylamine Imidazoles Ciclopirox Benzylamine Tolnaftate Undecenoic acid OnychomycosisCiclopirox Amorolfine Systemic Treatment Adults: Terbinafine, 250 mg/day x 2 weeks Itraconazole, 200 mg twice daily x 1 week Fluconazole, 150 mg/week x 3–4 weeks Children: Terbinafine, 3–6 mg/kg/day x 2 weeks Itraconazole, 5 mg/kg/day x 2 weeks Adults: Terbinafine, 250 mg/day x 6–12 weeks Itraconazole, 200 mg/day x 2–3 months Fluconazole, 150–300 mg/week x 3–12 months Children: Terbinafine, 3–6 mg/kg/day x 6–12 weeks Itraconazole, 5 mg/kg/day x 2–3 months Fluconazole, 6 mg/kg/week x 3–6 months Tinea capitis •Etiology species of genera Trichophyton and Microsporum •three distinctly different forms gray patch black dot favus •3 types of Hair invasion Ectothrix species: Conidia form on the exterior of the hair shaft. Endothrix species: Conidia form within the hair shaft, each is filled with hyphae and spores. Favus species: Hyphae arrange within and around the hair shaft. Kerion: Thick plaques and boggy skin form often with bacterial infection superimposed Clinical features of Tinea capitis •begins as a small erythematous papule around a hair shaft on the scalp, eyebrows, or eyelashes. •numerous red papules-with a typical ring form with paler and scaly •hairs appear-discolored, lusterless, and brittle •Pruritus usually minimal •Alopecia (hair loss)-with hairs breaking is common •Inflammation may be mild or severe Differential Diagnosis of Tinea Capitis • Most Likely Seborrheic dermatitis, contact dermatitis, pustular or plaque psoriasis, atopic dermatitis, bacterial pyodermas, folliculitis decalvans, lichen planopilaris, and dissecting cellulitis of the scalp • Consider Alopecia areata, trichotillomania, pseudopelade Rule Out Subacute cutaneous lupus erythematosus, syphilis Laboratory Studies for diagnosis •Direct microscopic examination plucked hairs are treated with KOH -Spores within or around the hair shaft can be detected. •Fungal cultures can be performed for identification of the species. •Wood light (UV light) examination may be performed. •Histology is only needed for some cases Tinea capitis hyphae and spores around the hair shaft (KOH) Tinea capitis Wood lamp examination of a gray-patch area on the scalp In Microsporum canis infection, scalp hairs emit a diagnostic brilliant green fluorescence. an endoectothrix invasion of a hair shaft by Microsporum audouinii. Intrapilary hyphae and spores around the hair shaft are seen (HE with PAS). Tinea capitis Fungal hyphae and yeast cells of Trichophyton rubrum seen on the stratum corneum of tinea capitis. PAS stain Treatment of Tinea capitis antifungal medications-itraconazole, terbinafine, ketoconazole, griseofulvin and fluconazole, topical agents Selenium sulfide shampoo antifungal creams, lotions, solutions, powders, sprays tinea corporis is a superficial dermatophyte infection on the glabrous skin (ie, skin regions except the scalp, groin, palms, and soles) Etiology caused by a variety of dermatophytes, mainly T tonsurans & also M canis & T rubrum. Clinical feature of Tinea corporis Lesion-• begins as an erythematous, scaly plaque crust, vesicles • characterized by annular with raised edges • on the exposed skin of trunk and extremities • may rapidly worsen and enlarge Tinea of feet and hands •Tinea pedis – is the term used for a dermatophyte infection of the soles of the feet and the interdigital spaces •Tinea manuum– fungal infection of the palms and finger webs Clinical features of Tinea pedis 4 possible clinical presentations: Interdigital tinea pedis Chronic hyperkeratotic tinea pedis Inflammatory/vesicular tinea pedis Ulcerative tinea pedis Lesions-•scaling, painful fissuring, maceration; •erythema; •vesicles; pustules; and bullae Onychomycosis (OM) Tinea unguim • a fungal infection that affects the toenails or fingernails • may involve any component of the nail unit including the nail matrix, nail bed, or nail plate The main subtypes: distal lateral subungual onychomycosis (DLSO) white superficial onychomycosis (WSO) proximal subungual onychomycosis (PSO) endonyx onychomycosis (EO) candidal onychomycosis *may have a combination of these subtypes *Total dystrophic onychomycosis refers to the most advanced form of any subtype Clinical features of OM • usually asymptomatic first present for cosmetic reasons without any complaints •may interfere with standing, walking, and exercising •may report paresthesia, pain, discomfort, and loss of dexterity •may report loss of self-esteem and lack of social interaction •A careful history may reveal many environmental & occupational risk factors Diagnosis of onychomycosis Direct microscopy A 20% potassium hydroxide (KOH) Culture identify the species of organism Histologic Findings nail biopsy & PAS staining (periodic acid-Schiff stain) most sensitive technique available to diagnose Treatment Topical antifungals amorolfine (approved in other countries), ciclopirox olamine 8% nail lacquer solution, bifonazole/urea (available outside the United States) Oral therapy oral antifungal agents (itraconazole and terbinafine) Derivatives of fluconazole Surgical Care Surgical approaches: mechanical, chemical, or surgical nail avulsion combination of oral, topical, and surgical therapy can increase efficacy and reduce cost pityriasis versicolor Tinea versicolor • Clinical features a common, benign, superficial cutaneous fungal infection characterized by hypopigmented or hyperpigmented macules and patches on chest & back. The color of lesion: white to reddish brown or fawn colored fail to tan in the summer may chronically recur • Etiology the dimorphic, lipophilic organisms in the genus Malassezia, formerly known as Pityrosporum. • diagnosis usually confirmed by potassium hydroxide (KOH) pityriasis versicolor white to reddish brown or fawn colored macules Treatment topical agents selenium sulfide, sodium sulfacetamide, ciclopiroxolamine, as well as azole and allylamine antifungals Oral therapy Ketoconazole, fluconazole, and itraconazole does not prevent the high rate of recurrence --repeated intermittently throughout the year. Thank you & Qs